Login / Signup

Is prolonged monitoring necessary? An updated approach to infantile hemangioma treatment with oral propranolol.

Maija Liv JohansenGeetha MahendranLeslie P Lawley
Published in: Pediatric dermatology (2021)
Prolonged in-office monitoring of propranolol initiation and dose escalation (Protocol 1) may not be necessary for the setting of adequate prescreening as it does not predict immediate or future adverse events.
Keyphrases
  • randomized controlled trial
  • current status
  • open label
  • clinical trial
  • combination therapy